JSMC
Jess S. Morgan & Co Portfolio holdings
AUM
$115M
This Quarter Return
+12.89%
1 Year Return
-16.65%
3 Year Return
+69.29%
5 Year Return
–
10 Year Return
–
AUM
$152M
AUM Growth
+$152M
(+6.6%)
Cap. Flow
-$4.53M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
32.37%
Holding
44
New
–
Increased
28
Reduced
12
Closed
4
Top Buys
| 1 |
CKPT
Checkpoint Therapeutics
CKPT
|
$1.56M |
| 2 |
Axsome Therapeutics
AXSM
|
$1.02M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
$974K |
| 4 |
AGEN
Agenus
AGEN
|
$948K |
| 5 |
SPDR S&P Biotech ETF
XBI
|
$595K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$3.35M |
| 2 |
PARA
Paramount Global Class B
PARA
|
$2.56M |
| 3 |
MediciNova
MNOV
|
$2.52M |
| 4 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$2.28M |
| 5 |
Oramed Pharmaceuticals
ORMP
|
$772K |
Sector Composition
| 1 | Healthcare | 24.89% |
| 2 | Technology | 11.42% |
| 3 | Financials | 8.35% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Consumer Staples | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amgen
AMGN
$155B
| $4.02M | 2.64% | 16,509 +1,629 | +11% | +$397K |
|
27
Walt Disney
DIS
$213B
| $3.99M | 2.62% | 22,705 +2,120 | +10% | +$373K |
|
28
Salesforce
CRM
$245B
| $3.98M | 2.62% | 16,307 +1,245 | +8% | +$304K |
|
|
29
Vanguard Total International Stock ETF
VXUS
$102B
| $3.87M | 2.54% | 58,840 +14,830 | +34% | +$974K |
|
30
Johnson & Johnson
JNJ
$427B
| $3.84M | 2.52% | 23,288 +1,395 | +6% | +$230K |
|
31
Cheesecake Factory
CAKE
$3.06B
| $3.76M | 2.47% | 69,395 -109 | -0.2% | -$5.91K |
|
|
IFN
32
India Fund
IFN
$601M
| $3.7M | 2.43% | 168,494 +2,225 | +1% | +$48.9K |
|
|
CKPT
33
DELISTED
Checkpoint Therapeutics
CKPT
| $3.32M | 2.18% | 1,125,782 +530,082 | +89% | +$1.56M |
|
34
Technology Select Sector SPDR Fund
XLK
$83.9B
| $2.44M | 1.61% | 16,551 +656 | +4% | +$96.9K |
|
35
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.31B
| $1.34M | 0.88% | 45,667 +1,200 | +3% | +$35.3K |
|
36
Vanguard Total Stock Market ETF
VTI
$526B
| $1.34M | 0.88% | 6,020 -265 | -4% | -$59K |
|
37
iShares Expanded Tech-Software Sector ETF
IGV
$9.84B
| $1.23M | 0.81% | 3,154 +24 | +0.8% | +$9.36K |
|
38
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $1.2M | 0.79% | 9,552 +28 | +0.3% | +$3.53K |
|
39
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $915K | 0.6% | 13,080 +655 | +5% | +$45.8K |
|
|
RNTX
40
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $94K | 0.06% | 75,000 +10,000 | +15% | +$12.5K |
|
|
41
MediciNova
MNOV
$64.3M
| – | – | -498,688 | Closed | -$2.52M |
|
|
PARA
42
DELISTED
Paramount Global Class B
PARA
| – | – | -56,645 | Closed | -$2.56M |
|
|
PRVB
43
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| – | – | -217,050 | Closed | -$2.28M |
|
|
44
Bristol-Myers Squibb
BMY
$96B
| – | – | -53,024 | Closed | -$3.35M |
|